Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to work helping them grow and metastasize (spread). Researchers have now discovered a potential therapy that can disrupt this recruitment and abnormal function of myeloid cells in laboratory mice.
